With the help of the intellectual property law clinics at Indiana University Maurer School of Law and Notre Dame Law Schools, inventors are securing patents and protections that could give their ideas the commercial boost the need to compete in the marketplace.
Detecting cancers and cardiovascular diseases now may be a bit easier thanks to a new patent secured by the Notre Dame Law School’s Intellectual Property and Entrepreneurship Clinic. The portable invention may help doctors detect such serious diseases faster and more economically by using biomarkers.
The U.S. Patent and Trademark Office has designated the Indiana University Maurer School of Law’s Center for Intellectual Property Research as the patent hub for the commonwealth of Kentucky, expanding the center’s previous designation as Indiana’s patent hub.
Accused infringers might have a greater incentive to save their patent invalidity arguments for federal court or International Trade Commission litigation after the U.S. Supreme Court renders its decision in SAS Institute, Inc. v. Matal, U.S., No. 16-969.
Although it only affirms what has been said before, a September decision from the Federal Circuit Court of Appeals is nevertheless surging in popularity among inventors and their attorneys because it reminds the U.S. Patent and Trademark Office that the standard of “broadest reasonable interpretation” for evaluating patent applications does not mean “broadest possible interpretation.”
In the wake of hefty attorney fees and an onslaught of what was viewed as unnecessary litigation filed by “patent trolls,” Congress authorized the Patent Trial and Appeal Board to begin conducting inter partes reviews of patent challenges in 2012 as an efficient and cost-effective alternative to patent litigation. But now, the popular IPR process could be in jeopardy as the United States Supreme Court considers whether federal law requires patent challenges to be adjudicated in court.
A Delaware federal judge’s ruling this week in a medical-device patent-infringement suit against Bloomington-based Cook Medical further tightens venue choice rules in patent cases that were limited in a Supreme Court holding this year.
A pair of suppliers to the recreational vehicle industry are headed back to court after the U.S. Court of Appeals for the Federal Circuit revived the infringement claims made after a patented two-part seal was discovered on an RV in an Elkhart County, Indiana, factory.
A northern Indiana judge ruled that a recreational vehicle supplier’s patent-infringement suit against a competitor will move forward, in part because former employees of the plaintiff company are alleged to have encouraged infringement.
Apple is seeking to void some of Qualcomm's patent claims and licensing agreements, intensifying its legal battle with the chip maker over the technology in iPhones and iPads.
Recently, the Supreme Court of the United States made the problem of deciding where to incorporate a little more complicated. Sure, your client could still choose Delaware for its well-developed business laws. But how does Delaware stack up in patent litigation?
A unanimous United States Supreme Court is speeding up the time for generic biotech drugs to become available to the public in a ruling that means a loss of billions in sales to the makers of original versions.
In a decision that Zimmer Biomet and other medical device manufacturers argued will change their industry, the Supreme Court of the United States ruled Tuesday that patent holders cannot keep their patent protections after they sell their products.
The U.S. Supreme Court is making it easier for companies to defend themselves against patent infringement lawsuits.
The Supreme Court shook the foundations of the software patent world in 2012 (Mayo v. Prometheus) and 2014 (Alice Corp. v. CLS Bank International), leaving business leaders (and their patent attorneys) to wonder whether — or even hope that — software patents were dead.
Pharmaceutical and medical device manufacturers, including an orthopedic product maker in Indiana, have weighed in on a patent case that came before the Supreme Court of the United States Tuesday.
The Supreme Court of the United States on Wednesday sided with California-based Life Technologies Corp. in a patent infringement case that limits the international reach of U.S. patent laws.
Eli Lilly and Co. won an appeals court ruling Thursday that upheld the validity of a patent for its lung cancer drug Alimta, helping shares rise by almost 3 percent.
Nokia Oyj sued Apple Inc. saying the iPhone maker infringed several mobile patents, turning simmering tension between the companies into a bitter public legal battle on multiple fronts.
The U.S. Supreme Court agreed to consider putting sharp new limits on where patent-infringement lawsuits can be filed, accepting a case that may undercut patent owners’ ability to channel cases to favorable courts.